Filing metadata

Accession number
0001610717-24-000337
Form type
Form 4
Filer
Neumora Therapeutics, Inc.
CIK
CIK 1885522
Filed
Jun 14, 2024
Reporting period
Jun 13, 2024
Description
Insider transaction

Explore SEC Filings Hub